Aravind Asokan, PhD
Dr. Asokan engineers biological macromolecules and viruses for human gene therapy.
Pranam Chatterjee, PhD (beginning July 1, 2022)
Dr. Chatterjee develops diverse algorithmic modalities to discover, characterize, and engineer novel proteins for applications in genome editing, targeted protein modulation, and reproductive bioengineering.
Dr. Ciofani is interested in defining the transcriptional networks of T cell pathogenicity in autoimmune disease.
Dr. Crawford's research involves identifying gene regulatory elements across the genome to help us understand how chromatin structure dictates cell function and fate.
Dr. Diao's research is focused on developing new functional genomics tools to study genome structure and function and using skeletal muscle regeneration and muscle stem cell as a model system to study gene regulation of tissue regeneration in health and diseases conditions.
Dr. Gersbach's research is dedicated to applying innovative methods in molecular and genetic engineering to regenerative medicine, treating genetic disease, and enhancing our understanding of fundamental biological processes.
Dr. Gordân's lab develops quantitative computational and experimental approaches to identify and characterize transcriptional regulatory regions in the human genome.
Dr. Gregory is interested in elucidating the molecular mechanisms underlying multi-factorial diseases. His lab is primarily interested identifying the complex genetic factors that give rise to multiple sclerosis (MS) and autism.
Dr. Hartemink is interested in developing new algorithms in statistical machine learning and artificial intelligence and applying those methods to complex problems in computational genomics.
Dr. Kirsch is interested in utilizing mouse models of cancer to study cancer and radiation biology in order to develop new cancer therapies in the pre-clinical setting.
Anoop Patel, MD
Dr. Patel focuses on using single cell technologies to understand tumor heterogeneity, with a special focus on malignant brain tumors. His lab is specifically interested in how heterogeneity contributes to treatment resistance and uses patient samples and complex model systems to study tumor evolution during therapy.
Dr. Poss is interested in injury-induced regeneration of heart, spinal cored and appendages in zebrafish and exploratory methods to understand regeneration.
Dr. Reddy is focused on understanding how genetic variation that alters gene regulation contributes to human traits including risk for common diseases such as diabetes.
Dr. Tata is interested in defining gene regulatory networks in normal and pathological lung tissues at single cell resolution as well as using pharmacogenonmic apporaches to define signaling networks in lung stem cells.
Dr. Tung is interested in the social determinants of gene regulation in experimental animal models and wild pop